Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waldow, T.
Right arrow Articles by Knaut, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waldow, T.
Right arrow Articles by Knaut, M.
(Chest. 2004;125:2253-2259.)
© 2004 American College of Chest Physicians

Attenuation of Reperfusion-Induced Systemic Inflammation by Preconditioning With Nitric Oxide in an In Situ Porcine Model of Normothermic Lung Ischemia*

Thomas Waldow, MD; Konstantin Alexiou, MD; Wolfgang Witt, PhD; Florian M. Wagner, MD; Vassilios Gulielmos, MD; Klaus Matschke, MD and Michael Knaut, MD

* From the Cardiovascular Institute (Drs. Waldow, Alexiou, Witt, Gulielmos, Matschke, and Knaut), University Hospital Dresden, Dresden; and the Department of Cardiovascular Surgery (Dr. Wagner), University Hospital Eppendorf, Hamburg, Germany.

Correspondence to: Thomas Waldow, MD, Herzzentrum Dresden, Klinik für Kardiochirurgie, Fetscherstr. 76, 01307 Dresden, Germany

Study objectives: Inhalation of nitric oxide (NO) can ameliorate pulmonary ischemia/reperfusion (I/R) injury of the lung in several experimental models, but toxic effects of NO were also reported. Here we investigate whether NO inhalation for a short period prior to surgery is sufficient to prevent symptoms of lung I/R injury, especially the inflammatory response.

Design: Using an in situ porcine lung model, normothermic left lung ischemia was maintained for 90 min, followed by a 5-h reperfusion period (group 1, n = 7). In group 2 (n = 6), I/R was preceded by inhalation of NO (10 min, 15 ppm). Animals in group 3 (n = 7) underwent sham surgery without NO inhalation or ischemia.

Measurements: Oxygenation and hemodynamic parameters were measured as indicators of lung functional impairment. Plasma levels of interleukin (IL)-1ß, IL-6, and transforming growth factor (TGF)-ß1 were determined throughout the I/R maneuver. In addition, tissue macrophages were analyzed by lectin binding.

Results: Symptoms of I/R injury (pulmonary hypertension and decreased oxygenation) in group 1 animals were attenuated by NO inhalation. The reperfusion-induced increases of the levels of IL-1ß and IL-6 in plasma were reduced by NO pretreatment. A peak of TGF-ß1 immediately after NO administration was observed in group 2, but not in groups 1 and 3. There was no significant effect of NO on tissue macrophages.

Conclusion: NO inhalation for a short period prior to lung I/R is sufficient to protect against pulmonary hypertension, impaired oxygenation, and the inflammatory response of pulmonary I/R injury.

Key Words: cytokine • inflammation • lung • nitric oxide • pig • preconditioning • reperfusion injury




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Takashima, G. Koukoulis, H. Inokawa, M. Sevala, and T. M. Egan
Inhaled nitric oxide reduces ischemia-reperfusion injury in rat lungs from non-heart-beating donors
J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 132 - 139.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Chest Physicians.